Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 140   

Articles published

GSK 1,580.82 -4.68 (-0.30%)
price chart
GlaxoSmithKline could receive further Brexit boost, says broker
GlaxoSmithKline plc (LON:GSK) could receive a further Brexit boost if Prime Minister Theresa May takes a hard-line approach to the UK's disengagement from the European Union.
Simon Dingemans Buys 8 Shares of GlaxoSmithKline plc (GSK) Stock  Sports Perspectives
GlaxoSmithKline plc 10% Potential Upside Indicated by Jefferies International  DirectorsTalk Interviews
GlaxoSmithKline plc's (GSK) "Underperform" Rating Reaffirmed at BNP Paribas
GlaxoSmithKline plc logo BNP Paribas reiterated their underperform rating on shares of GlaxoSmithKline plc (LON:GSK) in a research note issued to investors on Sunday morning.
GlaxoSmithKline plc (GSK) Rating Reiterated by BNP Paribas  The Cerbat Gem
GlaxoSmithKline PLC (NYSE:GSK) declared EPS of 0.85  The Newburgh Press
J P Morgan Chase & Co Reiterates "Neutral" Rating for GlaxoSmithKline plc (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “neutral” rating reaffirmed by equities research analysts at J P Morgan Chase & Co in a report issued on Thursday.
The GlaxoSmithKline plc (GSK) – Investment Analysts' Recent Ratings ...  DailyQuint
GlaxoSmithKline plc (GSK) Insider Moncef Slaoui Acquires 58 Shares
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) insider Moncef Slaoui purchased 58 shares of the stock in a transaction dated Monday, January 9th.
what are Analysts report about: GlaxoSmithKline plc (NYSE:GSK)  News Oracle
EPS Of GlaxoSmithKline PLC (NYSE:GSK) At $0.62
In the looming financial release, the forecasters are expecting GlaxoSmithKline PLC (NYSE:GSK) to post EPS of $0.62 for the quarter.
Hoertkorn Richard Charles Buys Citigroup Inc, GlaxoSmithKline PLC, Wells Fargo ...
Hoertkorn Richard Charles initiated holdings in Salesforce.com Inc. The purchase prices were between $68.41 and $77.77, with an estimated average price of $72.57.
GlaxoSmithKline plc's (GSK) "Buy" Rating Reaffirmed at Bryan, Garnier & Co
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK)'s stock had its “buy” rating reaffirmed by stock analysts at Bryan, Garnier & Co in a research report issued on Monday.
GlaxoSmithKline plc (GSK) PT Lowered to GBX 1600  The Cerbat Gem
Why I'm bullish on GlaxoSmithKline plc for 2017
I believe GlaxoSmithKline (LSE: GSK) is one of the market's most undervalued and under-appreciated stocks. Over the past year, the company has gone from a business struggling to grow, to projected earnings per share growth of 30% this year and 10% for ...
Jefferies Group Raises GlaxoSmithKline plc (GSK) Price Target to GBX 1750
GlaxoSmithKline plc logo GlaxoSmithKline plc (LON:GSK) had its price objective lifted by equities research analysts at Jefferies Group from GBX 1,700 ($20.67) to GBX 1,750 ($21.28) in a research note issued to investors on Monday.
Reliable stocks in today's share market: GlaxoSmithKline plc (NYSE:GSK)  The News Journal
Stock Mover of the Day: GlaxoSmithKline plc (ADR) Declines Again; Strong ...  Fair View Times
Oral Vaccines Market 2017 GlaxoSmithKline Plc, Hualan Biological Engineering ...
13-Oral-Vaccines Top Manufacturers Analysis of Oral Vaccines GlaxoSmithKline Plc, Hualan Biological Engineering , Janssen Pharmaceuticals, MedImmune (US), Merck & Co.